Rare diseases
Investigational molecules
Locations
Back to Ireland324 clinical trials in Drogheda, Ireland. Every trial is listed in the EU Clinical Trials Register and updated daily.
Study on the Effects of Filgotinib for Children and Teenagers with Moderate to Severe Ulcerative Colitis
IrelandStudy of Vedolizumab for Children with Moderate to Severe Ulcerative Colitis or Crohn's Disease
IrelandStudy of Lutikizumab, ABBV-382, and Risankizumab for Adults with Moderate to Severe Crohn's Disease
IrelandStudy of olpasiran to prevent first major cardiovascular events in people with high levels of lipoprotein(a)
IrelandEfficacy and Safety Study of Paltusotine for Adults with Carcinoid Syndrome due to Well-Differentiated Neuroendocrine Tumors
IrelandAssessing Baxdrostat to Identify Primary Aldosteronism in Adults Newly Diagnosed with Untreated Hypertension
IrelandPhase II Study of Neoadjuvant ivonescimab with Paclitaxel and Carboplatin in Stage IIA‑IIIB (T3N2) Non‑Small Cell Lung Cancer Patients
IrelandEfficacy and safety of galvokimig in adults with non‑cystic fibrosis bronchiectasis: a randomized, double‑blind, placebo‑controlled phase 2 trial
IrelandFeasibility RCT of tirzepatide plus digital weight‑management program versus behavior change alone in women with obesity and infertility
IrelandPhase II Study of Gemcitabine Plus Ivonescimab in Adults with Advanced Non‑Small Cell Lung Cancer Resistant to Immunotherapy
IrelandEpcoritamab plus rituximab versus rituximab alone in elderly, frail or unfit patients with newly diagnosed diffuse large B‑cell lymphoma
IrelandSafety and Efficacy of Intrathecal BIIB115 in Infants with Spinal Muscular Atrophy Previously Treated with Onasemnogene Abeparvovec
IrelandThe busiest research cities in the country
What the registry says about research in the country
Innovative research focusing on inflammatory bowel diseases, including trials evaluating new therapeutic approaches for ulcerative colitis and Crohn's disease. Studies are examining novel compounds like obefazimod for improving patient outcomes.
Multiple trials are investigating endoscopic improvement and symptomatic remission in patients with moderate to severe conditions.
Groundbreaking research in preventing and treating various infections, with particular focus on Clostridioides difficile infection recurrence and surgical site infections following abdominal procedures.
Studies are evaluating novel preventive measures and treatment approaches to reduce infection rates.
Clinical research examining treatments for chronic skin conditions, with emphasis on Hidradenitis Suppurativa. Trials are evaluating new biological therapies like lutikizumab for moderate to severe cases.
Research focuses on improving symptoms and quality of life for patients with persistent skin disorders.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
